Related Companies
|
[]
|
|||||||||
Related Funds
|
[]
|
|||||||||
English
|
||||||||||
oda_Shareholders3Abstract|
|
|
|||||||||
oda_CorporateWebsiteAbstract|http://www.xbrl.org/2003/role/verboseLabel
|
|
|||||||||
oda_TheLinksToTheRelevantSectionsOfTheWebsiteProvidingTheInformationCommandedByThePrinciple211|http://www.xbrl.org/2003/role/verboseLabel
|
|
Investor Relations / Eczacıbaşı Pharmaceutical and Industrial Investment Co. / Financial Information / Special Case Disclosures and Presentations - Corporate Governance - General Assembly - Contact Us
|
||||||||
oda_WhenApplicableTheLinkToTheListOfShareholdersUltimateBeneficiariesWhoDirectlyOrIndirectlyOwnMoreThanFivePercentOfTheShares|http://www.xbrl.org/2003/role/verboseLabel
|
|
Investor Relations / Eczacıbaşı Pharmaceutical and Industrial Investment Co. / About Us / Shareholder Structure
|
||||||||
oda_ListOfLanguagesForWhichTheWebsiteIsAvailable|
|
|
Turkish and English
|
||||||||
oda_AnnualReportAbstract|http://www.xbrl.org/2003/role/verboseLabel
|
|
|||||||||
oda_ThePageNumberInTheAnnualReportWhereTheInformationRelatedToTheElementsInPrincipleAbstract|
|
|
|||||||||
oda_ThePageNumberOfTheInformationOnTheDutiesOfTheMembersOfTheBoardOfDirectorsAndExecutivesConductedOutOfTheCompanyAndDeclarationsOnIndependenceOfBoardMembers|http://www.xbrl.org/2003/role/verboseLabel
|
|
Corporate Governance / Board of Directors and Corporate Governance / Statements of Independence
|
||||||||
oda_ThePageNumberOfTheInformationOnTheCommitteesFormedWithinTtheStructureOfTheBoardOfDirectors|http://www.xbrl.org/2003/role/verboseLabel
|
|
Corporate Governance / Board of Directors
|
||||||||
oda_ThePageNumberThatIncludesTheNumberOfMeetingsOfTheBoardOfDirectorsInAYearAndAttendanceOfTheMembersOfBoardOfDirectorsToTheseMeetings|http://www.xbrl.org/2003/role/verboseLabel
|
|
Corporate Governance / Board of Directors
|
||||||||
oda_ThePageNumberThatIncludesTheInformationOnAmendmentsInTheLegislationWhichMaySignificantlyAffectTheActivitiesOfTheCorporation|http://www.xbrl.org/2003/role/verboseLabel
|
|
There are no legislative changes that may significantly affect the company's activities. Explanation is provided in the ?Other Legal Matters? section of the Annual Report.
|
||||||||
oda_ThePageNumberThatIncludesTheInformationOnSignificantLawsuitsFiledAgainstTheCorporationAndThePossibleResultsThereof|http://www.xbrl.org/2003/role/verboseLabel
|
|
There is no lawsuit filed against the company that may affect its financial situation. Explanation is provided in the ?Other Legal Matters? section of the Annual Report.
|
||||||||
oda_ThePageNumberOfTheInformationOnTheConflictsOfInterestOfTheCorporationAmongTheInstitutionsThatItPurchasesServicesOnMattersSuchAsInvestmentConsultingAndRatingAndTheMeasuresTakenByTheCorporationInOrderToAvoidFromTheseConflictsOfInterest|http://www.xbrl.org/2003/role/verboseLabel
|
|
Explanation is provided in the ?Other Legal Matters? section of the Annual Report.
|
||||||||
oda_ThePageNumberThatIncludesTheInformationOnTheCrossOwnershipSubsidiariesThatTheDirectContributionToTheCapitalExceedsFivePercent|http://www.xbrl.org/2003/role/verboseLabel
|
|
Explanation is provided in the ?Other Legal Matters? section of the Annual Report.
|
||||||||
oda_ThePageNumberOfTheInformationOnSocialRightsAndProfessionalTrainingOfTheEmployeesAndActivitiesOfCorporateSocialResponsibilityInRespectOfTheCorporateActivitiesThatArisesSocialAndEnvironmentalResults|http://www.xbrl.org/2003/role/verboseLabel
|
|
Corporate Governance section
|
Related Companies
|
[]
|
||||||||
Related Funds
|
[]
|
||||||||
English
|
|||||||||
oda_Stakeholders4Abstract|
|
|
||||||||
oda_CorporationsPolicyOnStakeholdersAbstract|http://www.xbrl.org/2003/role/verboseLabel
|
|
||||||||
oda_LinkToEmployeeRemedyOrSeverancePolicy|http://www.xbrl.org/2003/role/verboseLabel
|
|
Although there is no written compensation policy in the internal regulations, the compensation rights of the stakeholders are governed in accordance with the norms of the Turkish law and international law.
|
|||||||
oda_TheNumberOfDefinitiveConvictionsTheCompanyWasSubjectToInRelationToBreachOfEmployeeRights|
|
|
None.
|
|||||||
oda_ThePositionOfThePersonResponsibleForTheAlertMechanism|
|
|
Eczacıbaşı Group Compliance Board
|
|||||||
oda_TheContactOfThePersonResponsibleForTheAlertMechanism|http://www.xbrl.org/2003/role/verboseLabel
|
|
E-mail: uyum@eczacibasi.com.tr Phone: (0 212) 371 72 72 Fax: (0 212) 371 72 66
|
|||||||
oda_SupportingTheParticipationOfTheStakeholdersInTheCorporationsManagementAbstract|http://www.xbrl.org/2003/role/verboseLabel
|
|
||||||||
oda_LinkToTheInternalRegulationAddressingTheParticipationOfEmployeesOnManagementBodies|http://www.xbrl.org/2003/role/verboseLabel
|
|
Eczacıbaşı Group's internal regulations are not publicly available.
|
|||||||
oda_CorporateBodiesWhereEmployeesAreActuallyRepresented|
|
|
Eczacıbaşı Group's employees participate in Occupational Health and Safety Committee, Sustainability Commissions, and Equal Opportunity Committees.
|
|||||||
oda_HRPolicyAbstract|http://www.xbrl.org/2003/role/verboseLabel
|
|
||||||||
oda_TheRoleOfTheBoardOnDevelopingAndEnsuringThatTheCompanyHasASuccessionPlanForTheKeyManagementPositions|
|
|
Succession plans for key executive positions are developed by the Company's Human Resources Planning Committee. They are followed by Talent and Remuneration Committees across the organization and the Group.
|
|||||||
oda_LinkOrSummaryOfTheHRPolicyCoveringEqualOpportunitiesAndHiringPrinciples|http://www.xbrl.org/2003/role/verboseLabel
|
|
The Gender Equality and Equal Opportunities Policy is available at www.eczacibasi.com.tr under Investor Relations / Eczacıbaşı Pharmaceutical and Industrial Investment Co. / Corporate Governance / Company Policies / Gender Equality and Equal Opportunities Policy, while the summary of human resources policy which contains the personnel recruitment criteria is available at www.eczacibasi.com.tr under Come Alive at Eczacıbaşı / Come Alive for Your Career.
|
|||||||
oda_WhetherTheCompanyProvidesAnEmployeeStockOwnershipProgramme|
|
|
Pay edindirme planı bulunmuyor (There isn't an employee stock ownership programme)
|
|||||||
oda_LinkOrReferenceTheHRPolicyCoveringDiscriminationAndMistreatmentsAndTheMeasuresToPreventThem|http://www.xbrl.org/2003/role/verboseLabel
|
|
Eczacıbaşı Group's human resources policy, which describes measures to prevent discrimination and ill-treatment, is available at www.eczacibasi.com.tr under Code of Conduct.
|
|||||||
oda_TheNumberOfDefinitiveConvictionsTheCompanyIsSubjectToTheRelationToHealthAndSafetyMeasures|
|
|
0
|
|||||||
oda_EthicalRulesAndSocialResponsibilityAbstract|http://www.xbrl.org/2003/role/verboseLabel
|
|
||||||||
oda_LinkToTheCodeOfEthics|http://www.xbrl.org/2003/role/verboseLabel
|
|
Investor Relations / Eczacıbaşı Pharmaceutical and Industrial Investment Co. / Corporate Governance / Code of Conduct
|
|||||||
oda_LinkToTheCSRReportIfThereIsntTheInformationAboutPrecautionsAboutEnvironmentalSocialAndCorporateGovernance|http://www.xbrl.org/2003/role/verboseLabel
|
|
Information on the corporate responsibility activities carried out across the Eczacıbaşı Group is available at www.eczacibasi.com.tr under For Our Future / Social Responsibility. Additionally, the Environmental, Social, Corporate Governance Policy is published at www.eczacibasi.com.tr under Investor Relations / Eczacıbaşı Pharmaceutical and Industrial Investment Co. / Corporate Governance / Company Policies / Environmental, Social, Corporate Governance Policy.
|
|||||||
oda_AnyMeasuresCombatingAnyKindOfCorruptionIncludingEmbezzlementAndBribery|
|
|
The measures taken by the Eczacıbaşı Group to fight corruption are described in the Code of Conduct booklet, which is available at www.eczacibasi.com.tr under Code of Conduct.
|
Related Companies
|
[]
|
|||||||||||||||
Related Funds
|
[]
|
|||||||||||||||
English
|
||||||||||||||||
oda_BoardOfDirectors1Abstract|
|
|
|||||||||||||||
oda_PrinciplesOfActivityOfTheBoardOfDirectorsAbstract|http://www.xbrl.org/2003/role/verboseLabel
|
|
|||||||||||||||
oda_DateOfTheLastBoardEvaluationConducted|
|
|
01/03/2024
|
||||||||||||||
oda_WhetherTheBoardEvaluationWasExternallyFacilitated|
|
|
Hayır (No)
|
||||||||||||||
oda_WhetherAllBoardMembersReleasedFroTheirDutiesAtTheGSM|
|
|
Evet (Yes)
|
||||||||||||||
oda_NamesOfTheBoardMembersWithSpecificDelegatedDutiesAndAuthoritiesAndDescriptionsOfSuchDuties|
|
|
No delegation of authority took place among the Board Members.
|
||||||||||||||
oda_NumberOfReportsPresentedByInternalAuditorsToTheAuditCommitteeOrAnyRelevantCommitteeToTheBoard|
|
|
0
|
||||||||||||||
oda_LinkToAnnualReportPageNumberOfTheSummaryReviewOfTheEffectivenessOfInternalControls|http://www.xbrl.org/2003/role/verboseLabel
|
|
Risk Management and Internal Audit Activities
|
||||||||||||||
oda_NameOfTheChairman|
|
|
Ferit Bülent Eczacıbaşı
|
||||||||||||||
oda_NameOfTheCEO|
|
|
Emin Fadıllıoğlu (CEO)
|
||||||||||||||
oda_IfTheCEOAndChairFunctionsAreCombinedProvideTheLinkToTheRelevantPDPPageProvidingTheRationaleForSuchCombinedRoles|
|
|
These roles are not occupied by the same person.
|
||||||||||||||
oda_LinkToNotificationRegardingCorporationsDamageThatMayBeCausedDueToTheFaultsOfBoardOfDirectorsDuringTheChargeOfTheirDutiesWasInsuredForAnAmountExceeding25PercentOfTheCorporationsCapital|
|
|
Insurance coverage has been provided under the Group's umbrella insurance, and the insurance amount exceeds 25% of the Company's capital. No PDP announcement was made as the insurance is under the Group's umbrella insurance.
|
||||||||||||||
oda_LinkToCurrentDiversityPolicyTargetingWomenDirectors|http://www.xbrl.org/2003/role/verboseLabel
|
|
Investor Relations / Eczacıbaşı Pharmaceutical and Industrial Investment Co. / Corporate Governance / Company Policies / Gender and Equal Opportunity Policy
|
||||||||||||||
oda_TheNumberOfFemaleDirectors|http://www.xbrl.org/2003/role/verboseLabel
|
|
Number: 1. Percentage: 16.67%
|
||||||||||||||
|
||||||||||||||||
Composition of Board of Directors
|
||||||||||||||||
Name, Surname of Board Member
|
Whether Executive Director Or Not
|
Whether Independent Director Or Not
|
The First Election Date To Board
|
Link To PDP Notification That Includes The Independency Declaration
|
Whether the Independent Director Considered By The Nomination Committee
|
Whether She/He is the Director Who Ceased to Satisfy The Independence or Not
|
Whether The Director Has At Least 5 Years’ Experience On Audit, Accounting And/Or Finance Or Not
|
|||||||||
Ferit Bülent Eczacıbaşı
|
İcrada Görevli Değil (Non-executive)
|
Bağımsız üye değil (Not independent director)
|
03/04/1981
|
-
|
İlgisiz (Not applicable)
|
İlgisiz (Not applicable)
|
-
|
|||||||||
Rahmi Faruk Eczacıbaşı
|
İcrada Görevli Değil (Non-executive)
|
Bağımsız üye değil (Not independent director)
|
31/03/1993
|
-
|
İlgisiz (Not applicable)
|
İlgisiz (Not applicable)
|
-
|
|||||||||
Atalay Muharrem Gümrah
|
İcrada Görevli Değil (Non-executive)
|
Bağımsız üye değil (Not independent director)
|
12/04/2018
|
-
|
İlgisiz (Not applicable)
|
İlgisiz (Not applicable)
|
Evet (Yes)
|
|||||||||
Seyfettin Sarıçam
|
İcrada Görevli Değil (Non-executive)
|
Bağımsız üye değil (Not independent director)
|
09/04/2020
|
-
|
İlgisiz (Not applicable)
|
İlgisiz (Not applicable)
|
Evet (Yes)
|
|||||||||
Hasan Toker Alban
|
İcrada Görevli Değil (Non-executive)
|
Bağımsız üye (Independent director)
|
12/04/2018
|
https://www.kap.org.tr/tr/Bildirim/1123568
|
Değerlendirildi (Considered)
|
Hayır (No)
|
Evet (Yes)
|
|||||||||
Zühal Atanan
|
İcrada Görevli Değil (Non-executive)
|
Bağımsız üye (Independent director)
|
12/04/2018
|
https://www.kap.org.tr/tr/Bildirim/1123568
|
Değerlendirildi (Considered)
|
Hayır (No)
|
Evet (Yes)
|
Related Companies
|
[]
|
|||||||||
Related Funds
|
[]
|
|||||||||
English
|
||||||||||
oda_BoardOfDirectors2Abstract|
|
|
|||||||||
oda_ProcedureOfBoardOfDirectorsMeetingsAbstract|http://www.xbrl.org/2003/role/verboseLabel
|
|
|||||||||
oda_NumberOfPhysicalBoardMeetingsInTheReportingPeriod|
|
|
4 physical meetings (the other 20 meeting decisions were taken by circulating the related documents.)
|
||||||||
oda_DirectorAverageAttendanceRateAtBoardMeetings|
|
|
% 96,3
|
||||||||
oda_WhetherTheBoardUsesAnElectronicPortalToSupportItsWorkOrNot|
|
|
Hayır (No)
|
||||||||
oda_NumberOfMinimumDaysAheadOfTheBoardMeetingToProvideInformationToDirectorsAsPerTheBoardCharter|
|
|
The documents on the agenda items are submitted by the secretariat to the Board Members at least three (3) business days prior to the meeting date.
|
||||||||
oda_LinkToTheBoardCharter|http://www.xbrl.org/2003/role/verboseLabel
|
|
Investor Relations / Eczacıbaşı Pharmaceutical and Industrial Investment Co. / Corporate Governance / Working Procedures and Principles of the Board of Directors
|
||||||||
oda_NumberOfMaximumExternalCommitmentsForBoardMembersAsPerThePolicyCoveringTheNumberOfExternalDutiesHeldByDirectors|
|
|
There is no such policy in place. However, as a principle, Board Members can take on roles in Eczacıbaşı Group's affiliates, while they cannot take on roles in other companies outside the Group.
|
||||||||
oda_BoardCommitteesAbstract|http://www.xbrl.org/2003/role/verboseLabel
|
|
|||||||||
oda_LinkToTheRelevantPagesOfTheAnnualReportAboutBoardCommittees|http://www.xbrl.org/2003/role/verboseLabel
|
|
Corporate Governance / Board of Directors
|
||||||||
oda_LinksToThePDPWithTheBoardCommitteeCharters|
|
|
https://www.kap.org.tr/tr/Bildirim/817970 ; https://www.kap.org.tr/tr/Bildirim/820231
|
||||||||
|
||||||||||
Composition of Board Committees-I
|
||||||||||
Names Of The Board Committees
|
Name Of Committees Defined As "Other" In The First Column
|
Name-Surname of Committee Members
|
Whether Committee Chair Or Not
|
Whether Board Member Or Not
|
||||||
Denetim Komitesi (Audit Committee)
|
-
|
Hasan Toker Alban
|
Evet (Yes)
|
Yönetim kurulu üyesi (Board member)
|
||||||
Denetim Komitesi (Audit Committee)
|
-
|
Zühal Atanan
|
Hayır (No)
|
Yönetim kurulu üyesi (Board member)
|
||||||
Kurumsal Yönetim Komitesi (Corporate Governance Committee)
|
-
|
Hasan Toker Alban
|
Evet (Yes)
|
Yönetim kurulu üyesi (Board member)
|
||||||
Kurumsal Yönetim Komitesi (Corporate Governance Committee)
|
-
|
Seyfettin Sarıçam
|
Hayır (No)
|
Yönetim kurulu üyesi (Board member)
|
||||||
Kurumsal Yönetim Komitesi (Corporate Governance Committee)
|
-
|
Simay Ağaçdiken Ünal
|
Hayır (No)
|
Yönetim kurulu üyesi değil (Not board member)
|
||||||
Riskin Erken Saptanması Komitesi (Committee of Early Detection of Risk)
|
-
|
Zühal Atanan
|
Evet (Yes)
|
Yönetim kurulu üyesi (Board member)
|
||||||
Riskin Erken Saptanması Komitesi (Committee of Early Detection of Risk)
|
-
|
Atalay Muharrem Gümrah
|
Hayır (No)
|
Yönetim kurulu üyesi (Board member)
|
Related Companies
|
[]
|
|||||||||||
Related Funds
|
[]
|
|||||||||||
English
|
||||||||||||
oda_BoardOfDirectors3Abstract|
|
|
|||||||||||
oda_BoardCommitteesAbstract|http://www.xbrl.org/2003/role/terseLabel
|
|
|||||||||||
oda_LinkToTheRelevantAnnualReportPageDescribingTheActivitiesOfTheAuditCommittee|http://www.xbrl.org/2003/role/verboseLabel
|
|
Annual Report / Corporate Governance / Board of Directors / Audit Committee
|
||||||||||
oda_LinkToTheRelevantAnnualReportPageDescribingTheActivitiesOfTheCorporateGovernanceCommittee|http://www.xbrl.org/2003/role/verboseLabel
|
|
Annual Report / Corporate Governance / Board of Directors / Corporate Governance Committee
|
||||||||||
oda_LinkToTheRelevantAnnualReportPageDescribingTheActivitiesOfTheNominationCommittee|http://www.xbrl.org/2003/role/verboseLabel
|
|
No separate Nomination Committee was formed pursuant to article 4.5.1 of the Communiqué no. II.171; the duties of the Nomination Committee are fulfilled by the Corporate Governance Committee. Annual Report / Corporate Governance / Board of Directors / Corporate Governance Committee.
|
||||||||||
oda_LinkToTheRelevantAnnualReportPageDscribingTheActivitiesOfTheCommitteeOfEarlyDetectionOfRisk|http://www.xbrl.org/2003/role/verboseLabel
|
|
Annual Report / Corporate Governance / Board of Directors / Early Detection of Risk Committee
|
||||||||||
oda_LinkToTheRelevantAnnualReportPageDescribingTheActivitiesOfTheRemunerationCommittee|http://www.xbrl.org/2003/role/verboseLabel
|
|
No separate Remuneration Committee was formed pursuant to article 4.5.1 of the Communiqué no. II.1711; the duties of the Remuneration Committee are fulfilled by the Corporate Governance Committee. Annual Report / Corporate Governance / Board of Directors / Corporate Governance Committee.
|
||||||||||
oda_FinancialRightsAbstract|http://www.xbrl.org/2003/role/verboseLabel
|
|
|||||||||||
oda_LinkToTheRelevantAnnualReportPagePresentingOperationalAndFinancialTargetsAndTheirAchievement|http://www.xbrl.org/2003/role/verboseLabel
|
|
Annual Report, Page 17
|
||||||||||
oda_LinkToTheCompanyWebsiteWithTheRemunerationPolicyForExecutiveAndNonExecutiveDirectors|http://www.xbrl.org/2003/role/verboseLabel
|
|
Investor Relations / Eczacıbaşı Pharmaceutical and Industrial Investment Co. / Corporate Governance / Remuneration Policy
|
||||||||||
oda_LinkToTheReportOnIndividualRemunerationForBoardMembersAndSeniorExecutivesInTheAnnualReport|http://www.xbrl.org/2003/role/verboseLabel
|
|
Corporate Governance / Benefits Granted to the Members of the Board of Directors and Senior Managers
|
||||||||||
|
||||||||||||
Composition of Board Committees-II
|
||||||||||||
Names Of The Board Committees
|
Name of committees defined as "Other" in the first column
|
The Percentage Of Non-executive Directors
|
The Percentage Of Independent Directors In The Committee
|
The Number Of Meetings Held In Person
|
The Number Of Reports On Its Activities Submitted To The Board
|
|||||||
Denetim Komitesi (Audit Committee)
|
-
|
% 100
|
% 100
|
4
|
8
|
|||||||
Kurumsal Yönetim Komitesi (Corporate Governance Committee)
|
-
|
% 67
|
% 33
|
3
|
6
|
|||||||
Riskin Erken Saptanması Komitesi (Committee of Early Detection of Risk)
|
-
|
% 100
|
% 50
|
6
|
7
|